Evaluation of the direct factor Xa inhibitor apixaban in rat models of thrombosis and hemostasis

被引：0
|
作者：
Schumacher, W. A. [1 ]
Bostwick, J. S. [1 ]
Stewart, A. B. [1 ]
Xin, B. [1 ]
Wong, P. C. [1 ]
机构：
[1] Bristol Myers Squibb, Thrombosis Res, Pennington, NJ USA
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2009年 / 7卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
PP-TH-202
引用
收藏
页码：1001 / 1001
页数：1
相关论文
共 50 条
  • [41] Comparative Antithrombotic and Antihemostatic Effects of the Direct Factor Xa Inhibitors, Apixaban and Rivaroxaban, and the Direct Thrombin Inhibitors, Dabigatran and Lepirudin, in Rabbit Models of Venous Thrombosis and Bleeding Time
    Wong, Pancras C.
    Crain, Earl, Jr.
    Watson, Carol
    BLOOD, 2008, 112 (11) : 1040 - 1041
  • [42] New oral Prophylaxis of venous Thromboembolism, Xa Inhibitor Apixaban factor
    Weiche, Iris
    Bauersachs, Rupert
    HAMOSTASEOLOGIE, 2011, 31 (04): : 310 - 310
  • [43] Preclinical pharmacokinetics and pharmacodynamics of apixaban, a potent and selective factor Xa inhibitor
    He, Kan
    Luettgen, Joseph M.
    Zhang, Donglu
    He, Bing
    Grace, James E., Jr.
    Xin, Baomin
    Pinto, Donald J. P.
    Wong, Pancras C.
    Knabb, Robert M.
    Lam, Patrick Y. S.
    Wexler, Ruth R.
    Grossman, Scott J.
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2011, 36 (03) : 129 - 139
  • [44] INHIBITION OF FACTOR XA IN BABOON THROMBOSIS MODELS
    HANSON, SR
    HARKER, LA
    LEVANON, A
    PANET, A
    WERBER, MM
    THROMBOSIS AND HAEMOSTASIS, 1995, 73 (06) : 1311 - 1311
  • [45] Arterial antithrombotic and bleeding time effects of apixaban, a direct factor Xa inhibitor, in combination with antiplatelet therapy in rabbits
    Wong, P. C.
    Watson, C. A.
    Crain, E. J.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2008, 6 (10) : 1736 - 1741
  • [46] Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays
    Hillarp, A.
    Gustafsson, K. M.
    Faxaelv, L.
    Strandberg, K.
    Baghaei, F.
    Blixter, I. Fagerberg
    Berndtsson, M.
    Lindahl, T. L.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2014, 12 (09) : 1545 - 1553
  • [47] Favorable therapeutic index of the direct factor Xa inhibitors, apixaban and rivaroxaban, compared with the thrombin inhibitor dabigatran in rabbits
    Wong, P. C.
    Crain, E. J.
    Watson, C. A.
    Xin, B.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 (08) : 1313 - 1320
  • [48] EFFECT OF APIXABAN, AN ORAL, DIRECT AND SELECTIVE FACTOR XA INHIBITOR ON INFLAMMATORY BIOMARKERS FOLLOWING ACUTE CORONARY SYNDROME
    Becker, Richard C.
    Lin, Annie
    Yang, Hongqiu
    Barrett, Yuchen
    Mohan, Puneet
    Wang, Jessie
    Alexander, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 57 (14) : E1039 - E1039
  • [49] The direct factor Xa inhibitor apixaban produces broad antithrombotic activity with limited effects on bleeding time in rats
    Schumacher, William A.
    Bostwick, Jeffrey S.
    Stewart, Anne B.
    Steinbacher, Thomas E.
    Pinto, Donald J.
    Wong, Pancras C.
    BLOOD, 2007, 110 (11) : 69B - 69B
  • [50] Effect of apixaban, an oral and direct factor Xa inhibitor, on coagulation activity biomarkers following acute coronary syndrome
    Becker, Richard C.
    Alexander, John H.
    Newby, L. Kristin
    Yang, Hongqiu
    Barrett, Yuchen
    Mohan, Puneet
    Wang, Jessie
    Harrington, Robert A.
    Wallentin, Lars C.
    THROMBOSIS AND HAEMOSTASIS, 2010, 104 (05) : 976 - 983
12345